195.96
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BDX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Becton Dickinson Co Borsa (BDX) Ultime notizie
Clinical Microbiology Market to Reach $6.9 Billion by 2029, Driven by Advanced Diagnostics and Regulatory Demand | MarketsandMarkets™. - GlobeNewswire Inc.
Diamond Hill Capital's Strategic Moves: Significant Reduction in Becton Dickinson & Co - Yahoo Finance
Director’s Bold Move: A Million-Dollar Bet on Becton Dickinson! - TipRanks
Judge OKs Becton Dickinson's $9M Investor Settlement - Law360
4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential - 24/7 Wall St.
BD Careers | Jobs at BD | We are the Makers of Possible - Becton Dickinson
Earnings Beat: Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - 富途牛牛
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $200 - 富途牛牛
Director Makes Significant Move with Becton Dickinson Stock! - TipRanks
J.P. Morgan Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $190 - 富途牛牛
A Quick Look at Today's Ratings for Becton Dickinson & Co(BDX.US), With a Forecast Between $183 to $200 - 富途牛牛
Becton Dickinson: Wells Fargo maintains Equal-Weight, raises PT to $184 from $172. - AInvest
Becton, Dickinson and Company (NYSE:BDX) Q3 2025 Earnings Call Transcript - Insider Monkey
Becton Dickinson price target raised to $200 from $185 at Piper Sandler - TipRanks
Piper Sandler raises Becton Dickinson stock price target to $200 on earnings beat - Investing.com
Becton Dickinson & Co (BDX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Becton Dickinson Reports Strong Q3 2025 Results - TipRanks
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MSN
Becton, Dickinson and Co’s Optimistic Earnings Call - TipRanks
Becton Dickinson: Fiscal Q3 Earnings Snapshot - Chron
Becton Dickinson and Co reports results for the quarter ended June 30Earnings Summary - TradingView
Becton Dickinson Q3 Beats Estimates On Medical Device Boom - inkl
Earnings call transcript: Becton Dickinson Q3 2025 earnings beat forecasts, stock surges - Investing.com
Becton Dickinson Earnings: Return to Organic Growth; Raised EPS Guidance; Shares Remain Undervalued - Morningstar
Becton, Dickinson stock rises on Q3 beat (BDX:NYSE) - Seeking Alpha
Becton, Dickinson and Company 2025 Q3ResultsEarnings Call Presentation (NYSE:BDX) - Seeking Alpha
Becton, Dickinson Boosts FY25 Adj. EPS OutlookUpdate - Nasdaq
Becton Dickinson Q3 FY25 presentation: Organic growth accelerates, guidance raised - Investing.com India
BD raises 2025 EPS guidance after strong Q3 performance - MassDevice
Becton Dickinson & Co Surpasses Q3 Estimates with $5.5 Billion Revenue and $3.68 Adjusted EPS - GuruFocus
Becton Dickinson shares surge as Q3 earnings beat drives guidance hike - Investing.com Nigeria
Becton Dickinson & Co Surpasses Q3 Estimates with $5.5 Billion R - GuruFocus
Becton Dickinson earnings beat by $0.28, revenue topped estimates - Investing.com
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test - Insider Monkey
First Eagle Investment's Strategic Moves: Spotlight on Becton Dickinson & Co - Yahoo Finance
Becton, Dickinson Q3 2025 Earnings Preview - MSN
Is Becton Dickinson (NYSE:BDX) A Risky Investment? - 富途牛牛
Stock Analysis | Becton, Dickinson OutlookA Cautious Call Amid Mixed Technical and Analyst Signals - AInvest
Becton Dickinson Stock Dips 1.12% as Volume Jumps 38.71% to $510M Ranking 232nd Amid Historic Supply Chain Certification - AInvest
Medical Giant BD Achieves Unprecedented Supply Chain Excellence with Perfect Score Across All 7 HIRC Categories - Stock Titan
Becton Dickinson & Co(BDX.US) Officer Sells US$514.14K in Common Stocks - 富途牛牛
BD to invest $35M to expand Nebraska syringe manufacturing - MassDevice
BD invests $35M to expand syringe plant in Nebraska - NJBIZ
Reshoring and Supply Chain Resilience: BD's Strategic Expansion in U.S. Medical Device Manufacturing and Its Implications for Long-Term Value Creation - AInvest
BD to Invest $35 Million in Nebraska Facility - citybiz
$35M Investment: BD Boosts Critical US Medical Supply Chain with Major Nebraska Factory Expansion - Stock Titan
Covington resident wins $20 million in case against Becton Dickinson - The Covington News
Becton Dickinson Stock Dives 1.81% Amid 100.16% Volume Spike to $670M Ranking 199th in Market Activity as FDA Submission Drives Volatility - AInvest
Earnings Preview: Becton Dickinson (BDX) Q3 Earnings Expected to Decline - Yahoo Finance
BD receives FDA clearance for rapid point-of-care COVID-19 test By Investing.com - Investing.com South Africa
BD receives FDA clearance for rapid point-of-care COVID-19 test - Investing.com
Becton Dickinson receives FDA clearance for BD Veritor System for SARS-CoV-2 - TipRanks
BD's New FDA-Cleared COVID Test Delivers Results in Just 15 Minutes: What Healthcare Providers Should Know - Stock Titan
Former Masimo COO Bilal Muhsin Joins BD - Orange County Business Journal
Is Becton Dickinson and Company stock overvalued or undervaluedBuild wealth faster with high-performing stocks - jammulinksnews.com
What are analysts’ price targets for Becton Dickinson and Company in the next 12 monthsAchieve breakthrough financial growth - jammulinksnews.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):